Cargando…
Commentary: Bladder cancer
Autores principales: | Qi, Yingzi, Tang, Dongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137006/ https://www.ncbi.nlm.nih.gov/pubmed/34084114 http://dx.doi.org/10.1097/CU9.0000000000000003 |
Ejemplares similares
-
Commentary: Treatment of prostate cancer
por: Lyu, Jiaju, et al.
Publicado: (2021) -
Invited Commentary: Beyond female stress urinary incontinence
por: Bai, Zhiming, et al.
Publicado: (2021) -
Invited commentary: When and how to initiate systemic therapy in treating favorable risk metastatic renal cell carcinoma
por: Inoue, Takahiro
Publicado: (2021) -
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
por: Kostine, Marie, et al.
Publicado: (2021) -
A novel index, Chinese visceral adiposity index is closely associated with urinary albumin‐creatinine ratio in Chinese community adults, especially in hypertensive or hyperglycemic population: Results from the REACTION study
por: Li, Binqi, et al.
Publicado: (2022)